Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

117.00
+1.571.36%
Post-market: 117.000.00000.00%19:30 EDT
Volume:734.30K
Turnover:86.16M
Market Cap:9.73B
PE:-36.42
High:119.63
Open:116.05
Low:114.35
Close:115.43
52wk High:130.05
52wk Low:43.74
Shares:83.15M
Float Shares:64.87M
Volume Ratio:1.10
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2122
EPS(LYR):-3.6900
ROE:-24.15%
ROA:-15.59%
PB:6.45
PE(LYR):-31.71

Loading ...

Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2025

Major Issues Report

Form 8-K - Current report